By proceeding, you agree to our Terms of Use and Privacy Policy.
The 3rd Next Generation Gene Therapy Vectors Summit is a gathering of industry leaders focused on advancing the field of gene therapy. With the emergence of new platforms and the need for safer vectors, the industry has rapidly expanded over the last year. The summit aims to bring together key players to discuss the future of the industry and explore new vector systems.Over three days, attendees will have the opportunity to participate in technical panel discussions, platform showcases, case studies, and seminars led by experts. This year's focus is on AAV vector design and the next generation vector systems competing with it. The summit's goal is to improve the safety, toxicity, specificity, and scalability of current gene therapy vectors. Join us to upgrade to the next generation of gene therapy vectors.
Deep dive into AAV vector design and the next generation vector systems competing with it.
Upgrade to the next generation with the only summit aimed at improving the safety, toxicity, specificity, and scalability of the current generation of gene therapy vectors.
Hear from experts across 3 days of technical panel discussions, platform showcases, case studies and seminars.
Connect with industry professionals to spark new ideas and discover fresh perspectives. Gain insights from keynote speeches, panel discussions, and expert-led sessions that will leave you inspired and ready to take on new challenges.
15-17 April 2024
Join us at the Festival of Biologics USA 2024, the most exciting biologics event in America! Taking place from April 15 to 17, 2024, at the renowned San Diego Convention Center, this three-day event will cover the entire journey of biologic drug deve
Event Started
USA
Paid
San Diego
18-19 April 2024
Join us at the MarketsandMarkets High Potent Medicines Conference, taking place on 19th - 20th October 2023, in Boston, USA. This groundbreaking conference is designed to address the emerging trends and challenges in the high potent medicines market.
Starts in 2 days
Boston
Hanson Wade gives people the clarity to see where opportunity lies. We work in highly specialised fields to provide unmatched depth and quality of content. We work in sectors where quality of information is the difference between success and failure.
SIRION Biotech was founded in 2005 with the goal to spark a new generation of viral vector technologies for gene and cell therapy as well as vaccine development.
At Ginkgo, we use biology to grow the future. Companies across industries leverage our platform to design, develop, and optimize products for a breadth of commercial applications.
Form empowers scientists to harness the data, computing power and collaboration that drive how today's breakthroughs are made.
For over 25 years, Mirus Bio has pioneered the development of transfection reagents and proprietary technologies for nucleic acid delivery applications. Our work is both technical and cutting-edge, and we promote a culture of creativity, responsibili
For over 25 years, Mirus Bio has pioneered the development of transfection reagents and proprietary technologies for nucleic acid delivery applications. Our work is both technical and cutting-edge, and we promote a culture of creativity, responsibility, and respect. Our team members are engaged and
All trademarks, registered trademarks, product names, and company names or logos mentioned in or on this site are the property of their respective owners.
A great community. Legit content. The kind of emails you actually look forward to.